Sony Tuteja

Assistant Professor

University of Pennsylvania

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Science Medical Science professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sony Tuteja is an Assistant Professor at the University of Pennsylvania, USA. His research primarily focuses on pharmacogenomics, particularly in the context of cancer treatment and cardiovascular health. Recent publications highlight his work on pharmacogenomic testing implementation and the establishment of multidisciplinary clinics aimed at improving patient outcomes.

Articles (17)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (15)

Teri E. Klein

UNITED STATES

Sony Tuteja

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Navigating Pharmacogenomic Testing in Practice: Who to Test and When to Test

Implementation of DPYD and UGT1A1 Testing in Patients With GI Cancer: A Prospective, Nonrandomized Clinical Trial

A call for reporting of tumor‐specific outcomes in studies of DPYD genotyping

Evaluation of Potential Racial Disparities in CYP2C19‐Guided P2Y12 Inhibitor Prescribing After Percutaneous Coronary Intervention

An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers

Establishing a patient‐centered, multidisciplinary pharmacogenomics clinic in an academic health system: Successes, challenges, and future direction

How to Run the Pharmacogenomics Clinical Annotation Tool (PharmCAT)

Application of Pharmacogenetics for the Use of Antiplatelet and Anticoagulant Drugs

Customizing the electronic health record for delivery of pharmacogenetics

Establishing a patient-centered, multidisciplinary pharmacogenomics clinic in an academic health system: Successes, challenges, and future direction

An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers

How to Run the Pharmacogenomics Clinical Annotation Tool (PharmCAT)

Evaluation of Potential Racial Disparities in <i>CYP2C19</i>-Guided P2Y<sub>12</sub> Inhibitor Prescribing After Percutaneous Coronary Intervention

CYP2C19 Genotype‐Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings

Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy

Pharmacogenetic variants and risk of remdesivir‐associated liver enzyme elevations in Million Veteran Program participants hospitalized with COVID‐19

Attitudes toward pharmacogenetics in patients undergoing CYP2C19 testing following percutaneous coronary intervention

Collaborators (15)

Teri E. Klein

Pawel Mroz

Yimei Huang

John Allen

Caitrin McDonough

Craig Lee

Glenda Hoffecker

Philip Empey

James Lee

Jasmine Luzum

Julio Duarte

Archna Bajaj

Nita Limdi

Larisa Cavallari

D. Max Smith

Make your next move.